Dr. Rui Avelar, Evolus Chief Medical Officer and Head of R&D, added, “The FDA approval of Evolysse™ Form and Evolysse™ Smooth reflects our commitment to bringing high-quality, innovative ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback